Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Irit Avni"'
Autor:
Jacob E. Ollech, Hagar Eran-Banai, Idan Goren, Tali Sharar Fischler, Irit Avni-Biron, Yifat Snir, Yelena Broitman, Shaked Cohen, Adi Friedenberg, Maor H. Pauker, Iris Dotan, Henit Yanai
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Introduction Real-world data on tofacitinib’s effectiveness is limited and mainly retrospective or registry-based. We elected to conduct a pragmatic prospective study to assess the efficacy of tofacitinib for moderate to severe ulcerative colitis (
Externí odkaz:
https://doaj.org/article/9ed4192db3f5459abdc38b3fc00a06b6
Autor:
Irit Avni-Biron, Ervin Toth, Jacob E. Ollech, Artur Nemeth, Gabriele Wurm Johansson, Hagai Schweinstein, Reuma Yehuda Margalit, Uri Kopylov, Iris Dotan, Henit Yanai
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1733 (2024)
Introduction: Complicated perianal disease (cPD) may be the sole presentation of Crohn’s disease (CD). The role of small-bowel capsule endoscopy (SBCE) in the diagnostic algorithm of cPD is unclear. We aimed to evaluate the role of SBCE as a diagno
Externí odkaz:
https://doaj.org/article/fd9c9713fb494a6e9a931efa8fe9ae7a
Autor:
Hadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Yelena Broitman, Haim Ben Zvi, Tsachi-Tsadok Perets, Rami Eliakim, Revital Barkan, Sophy Goren, Dani Cohen, Iris Dotan
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1263 (2023)
Vaccines are pivotal for control of the coronavirus disease (COVID-19) pandemic. Patients with inflammatory bowel diseases (IBDs) treated with antitumor necrosis factor (TNF)-α have lower serologic response after two COVID-19 vaccine doses. Data reg
Externí odkaz:
https://doaj.org/article/9af7d59e6bff4e7b8f461f8cd2945422
Autor:
Batia Weiss, Shomron Ben-Horin, Atar Lev, Efrat Broide, Miri Yavzori, Adi Lahat, Uri Kopylov, Orit Picard, Rami Eliakim, Yulia Ron, Irit Avni-Biron, Anat Yerushalmy-Feler, Amit Assa, Raz Somech, Ariella Bar-Gil Shitrit
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Background and aimAnti-TNFα is measurable in infants exposed in utero up to 12 months of age. Data about the exposure effect on the infant’s adaptive immunity are limited. We aimed to prospectively evaluate the distribution and function of T and B
Externí odkaz:
https://doaj.org/article/292e3f39f70b4f9e901229da3e826e41
Autor:
Henit Yanai, Bella Ungar, Uri Kopylov, Tali Sharar Fischler, Irit Avni Biron, Jacob E. Ollech, Idan Goren, Manar Matar, Tsachi Tsadok Perets, Raanan Shamir, Iris Dotan, Shira Amir, Amit Assa
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Background: Evidence regarding the risk of immunogenicity in patients with inflammatory bowel disease (IBD) who switched anti-tumor necrosis factor alpha (anti-TNFα) therapies to a subsequent anti-TNFα (either infliximab or adalimumab) is conflicti
Externí odkaz:
https://doaj.org/article/30e35f9753834cd797022ad1503b10ec
Autor:
Henit Yanai, Hadar Amir Barak, Jacob E Ollech, Irit Avni Biron, Idan Goren, Yifat Snir, Hagar Banai Eran, Yelena Broitman, Maya Aharoni Golan, Elena Didkovsky, Iris Amitay-Laish, Ayelet Ollech, Emmilia Hodak, Iris Dotan, Lev Pavlovsky
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background and Aims: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatment interruptions. We aimed to assess the impact of j
Externí odkaz:
https://doaj.org/article/88b32f4454734962ae309656aa9a48f8
Autor:
Irit Avni Biron, Yair Maayan, Tali Mishael, Eran Hadar, Michal Neeman, Romina Plitman Mayo, Hen Y. Sela, Simcha Yagel, Rosalind Goldenberg, Ami Ben Ya’acov, Sorina Grisaru Granovsky, Jacob E. Ollech, Hadar Edelman-Klapper, Keren Masha Rabinowitz, Maor H. Pauker, Henit Yanai, Sophy Goren, Dani Cohen, Iris Dotan, Ariella Bar-Gil Shitrit
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1833 (2022)
Introduction: Regulatory agencies supported vaccination of pregnant women with SARS-CoV-2 mRNA vaccines, including patients with IBD. No data exist regarding these vaccines in IBD during pregnancy. Aim: To assess the serologic response to two doses o
Externí odkaz:
https://doaj.org/article/b1b00f607d1c4c288cafeaf710c329b8
Autor:
Keren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben-Horin, Nitsan Maharshak, Michal Mor, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Tali Sharar-Fischler, Sophy Goren, Noy Krugliak, Edward Pichinuk, Michael Mor, Michal Werbner, Joel Alter, Hanan Abu-Taha, Kawsar Kaboub, Moshe Dessau, Meital Gal-Tanamy, Dani Cohen, Natalia T. Freund, Iris Dotan, on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1186 (2022)
Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNF
Externí odkaz:
https://doaj.org/article/002599bbb4e74664a74f8cb9e8c3051d
Autor:
Lev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya’acov, Irit Avni-Biron, Baruch Ovadia, Ofer Ben-Bassat, Timna Naftali, Uri Kopylov, Yael Haberman, Hagar Banai Eran, Rami Eliakim, Adi Lahat-Zok, Ayal Hirsch, Eran Zittan, Nitsan Maharshak, Matti Waterman, Eran Israeli, Idan Goren, Jacob E. Ollech, Henit Yanai, Bella Ungar, Benjamin Avidan, Dana Ben Hur, Bernardo Melamud, Ori Segol, Zippora Shalem, Iris Dotan, Selwyn H. Odes, Shomron Ben-Horin, Yf’at Snir, Yael Milgrom, Efrat Broide, Eran Goldin, Shmuel Delgado, Yulia Ron, Nathaniel Aviv Cohen, Eran Maoz, Maya Zborovsky, Safwat Odeh, Naim Abu Freha, Eyal Shachar, Yehuda Chowers, Tal Engel, Hila Reiss-Mintz, Arie Segal, Adar Zinger, Ariella Bar-Gil Shitrit
Publikováno v:
Vaccines, Vol 10, Iss 3, p 376 (2022)
Background: Crohn’s disease (CD) and ulcerative colitis (UC) are chronic, immune-mediated inflammatory bowel diseases (IBD) affecting millions of people worldwide. IBD therapies, designed for continuous immune suppression, often render patients mor
Externí odkaz:
https://doaj.org/article/eca69cf35e7040a98fb236c6175f11ed
Autor:
Vieujean, Sophie, Lindsay, James O, D'Amico, Ferdinando, Ahuja, Vineet, Silverberg, Mark S, Sood, Ajit, Yamamoto-Furusho, Jesus K, Nagahori, Masakazu, Watanabe, Mamoru, Koutroubakis, Ioannis E, Foteinogiannopoulou, Kalliopi, Biron, Irit Avni, Walsh, Alissa, Outtier, An, Nordestgaard, Rie Louise Møller, Abreu, Maria T, Dubinsky, Marla, Siegel, Corey, Louis, Edouard, Dotan, Iris
Publikováno v:
Journal of Crohn's & Colitis; Apr2024, Vol. 18 Issue 4, p548-559, 12p